These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 31570440

  • 1. Apatinib Reverses Paclitaxel-resistant Lung Cancer Cells (A549) Through Blocking the Function of ABCB1 Transporter.
    Zhang Q, Song Y, Cheng X, Xu Z, Matthew OA, Wang J, Sun Z, Zhang X.
    Anticancer Res; 2019 Oct; 39(10):5461-5471. PubMed ID: 31570440
    [Abstract] [Full Text] [Related]

  • 2. Apatinib (YN968D1) reverses multidrug resistance by inhibiting the efflux function of multiple ATP-binding cassette transporters.
    Mi YJ, Liang YJ, Huang HB, Zhao HY, Wu CP, Wang F, Tao LY, Zhang CZ, Dai CL, Tiwari AK, Ma XX, To KK, Ambudkar SV, Chen ZS, Fu LW.
    Cancer Res; 2010 Oct 15; 70(20):7981-91. PubMed ID: 20876799
    [Abstract] [Full Text] [Related]

  • 3. A Smart Paclitaxel-Disulfiram Nanococrystals for Efficient MDR Reversal and Enhanced Apoptosis.
    Mohammad IS, He W, Yin L.
    Pharm Res; 2018 Feb 27; 35(4):77. PubMed ID: 29488114
    [Abstract] [Full Text] [Related]

  • 4. Reversing Multidrug Resistance in Chemo-resistant Human Lung Adenocarcinoma (A549/DOX) Cells by Algerian Propolis Through Direct Inhibiting the P-gp Efflux-pump, G0/G1 Cell Cycle Arrest and Apoptosis Induction.
    Kebsa W, Lahouel M, Rouibah H, Zihlif M, Ahram M, Abu-Irmaileh B, Mustafa E, Al-Ameer HJ, Al Shhab M.
    Anticancer Agents Med Chem; 2018 Feb 27; 18(9):1330-1337. PubMed ID: 30088453
    [Abstract] [Full Text] [Related]

  • 5. Glaucarubinone sensitizes KB cells to paclitaxel by inhibiting ABC transporters via ROS-dependent and p53-mediated activation of apoptotic signaling pathways.
    Karthikeyan S, Hoti SL, Nazeer Y, Hegde HV.
    Oncotarget; 2016 Jul 05; 7(27):42353-42373. PubMed ID: 27304668
    [Abstract] [Full Text] [Related]

  • 6. Multiplicity of acquired cross-resistance in paclitaxel-resistant cancer cells is associated with feedback control of TUBB3 via FOXO3a-mediated ABCB1 regulation.
    Aldonza MB, Hong JY, Alinsug MV, Song J, Lee SK.
    Oncotarget; 2016 Jun 07; 7(23):34395-419. PubMed ID: 27284014
    [Abstract] [Full Text] [Related]

  • 7. Apatinib resensitizes cisplatin-resistant non-small cell lung carcinoma A549 cell through reversing multidrug resistance and suppressing ERK signaling pathway.
    Liu ZL, Jin BJ, Cheng CG, Zhang FX, Wang SW, Wang Y, Wu B.
    Eur Rev Med Pharmacol Sci; 2017 Dec 07; 21(23):5370-5377. PubMed ID: 29243778
    [Abstract] [Full Text] [Related]

  • 8. Morin reverses P-glycoprotein-mediated multidrug-resistance in KBChR-8-5 cancer cell lines.
    Zhao Y, Xu S, Hao W, Fu Y.
    Cell Biochem Funct; 2024 Jul 07; 42(5):e4083. PubMed ID: 38938150
    [Abstract] [Full Text] [Related]

  • 9. A multiple-targets alkaloid nuciferine overcomes paclitaxel-induced drug resistance in vitro and in vivo.
    Liu RM, Xu P, Chen Q, Feng SL, Xie Y.
    Phytomedicine; 2020 Dec 07; 79():153342. PubMed ID: 32992085
    [Abstract] [Full Text] [Related]

  • 10. BZML, a novel colchicine binding site inhibitor, overcomes multidrug resistance in A549/Taxol cells by inhibiting P-gp function and inducing mitotic catastrophe.
    Bai Z, Gao M, Zhang H, Guan Q, Xu J, Li Y, Qi H, Li Z, Zuo D, Zhang W, Wu Y.
    Cancer Lett; 2017 Aug 28; 402():81-92. PubMed ID: 28576750
    [Abstract] [Full Text] [Related]

  • 11. Crizotinib (PF-02341066) reverses multidrug resistance in cancer cells by inhibiting the function of P-glycoprotein.
    Zhou WJ, Zhang X, Cheng C, Wang F, Wang XK, Liang YJ, To KK, Zhou W, Huang HB, Fu LW.
    Br J Pharmacol; 2012 Jul 28; 166(5):1669-83. PubMed ID: 22233293
    [Abstract] [Full Text] [Related]

  • 12. Tangeretin, a citrus pentamethoxyflavone, antagonizes ABCB1-mediated multidrug resistance by inhibiting its transport function.
    Feng SL, Yuan ZW, Yao XJ, Ma WZ, Liu L, Liu ZQ, Xie Y.
    Pharmacol Res; 2016 Aug 28; 110():193-204. PubMed ID: 27058921
    [Abstract] [Full Text] [Related]

  • 13. Interleukin-22 (IL-22) Regulates Apoptosis of Paclitaxel-Resistant Non-Small Cell Lung Cancer Cells Through C-Jun N-Terminal Kinase Signaling Pathway.
    Li C, Zhao X, Yang Y, Liu S, Liu Y, Li X.
    Med Sci Monit; 2018 May 03; 24():2750-2757. PubMed ID: 29723165
    [Abstract] [Full Text] [Related]

  • 14. Nobiletin potentiates paclitaxel anticancer efficacy in A549/T xenograft model: Pharmacokinetic and pharmacological study.
    Feng SL, Tian Y, Huo S, Qu B, Liu RM, Xu P, Li YZ, Xie Y.
    Phytomedicine; 2020 Feb 03; 67():153141. PubMed ID: 31884406
    [Abstract] [Full Text] [Related]

  • 15. Discovery of novel pyrazolo[1,5-a]pyrimidine derivatives as potent reversal agents against ABCB1-mediated multidrug resistance.
    Fu XJ, Li N, Wu J, Wang ZY, Liu RR, Niu JB, Taleb M, Yuan S, Liu HM, Song J, Zhang SY.
    Eur J Med Chem; 2024 Nov 05; 277():116761. PubMed ID: 39151276
    [Abstract] [Full Text] [Related]

  • 16. Overcoming drug-resistant lung cancer by paclitaxel loaded tetrahedral DNA nanostructures.
    Xie X, Shao X, Ma W, Zhao D, Shi S, Li Q, Lin Y.
    Nanoscale; 2018 Mar 28; 10(12):5457-5465. PubMed ID: 29484330
    [Abstract] [Full Text] [Related]

  • 17. Apatinib sensitizes chemoresistant NSCLC cells to doxetaxel via regulating autophagy and enhances the therapeutic efficacy in advanced and refractory/recurrent NSCLC.
    Hu R, Li T, Hui K, Chen Z, Wang N, Wu X, Ge L, Zhou L.
    Mol Med Rep; 2020 Nov 28; 22(5):3935-3943. PubMed ID: 32901884
    [Abstract] [Full Text] [Related]

  • 18. Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2.
    Dai CL, Tiwari AK, Wu CP, Su XD, Wang SR, Liu DG, Ashby CR, Huang Y, Robey RW, Liang YJ, Chen LM, Shi CJ, Ambudkar SV, Chen ZS, Fu LW.
    Cancer Res; 2008 Oct 01; 68(19):7905-14. PubMed ID: 18829547
    [Abstract] [Full Text] [Related]

  • 19. Synergistic anticancer effects of andrographolide and paclitaxel against A549 NSCLC cells.
    Yuan H, Sun B, Gao F, Lan M.
    Pharm Biol; 2016 Nov 01; 54(11):2629-2635. PubMed ID: 27159496
    [Abstract] [Full Text] [Related]

  • 20. Suppression of MAPK Signaling and Reversal of mTOR-Dependent MDR1-Associated Multidrug Resistance by 21α-Methylmelianodiol in Lung Cancer Cells.
    Aldonza MB, Hong JY, Bae SY, Song J, Kim WK, Oh J, Shin Y, Lee SH, Lee SK.
    PLoS One; 2015 Nov 01; 10(6):e0127841. PubMed ID: 26098947
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.